Working at Akouos – Akouos
STEM Completes Lab Fit-Out for Akouos | High-Profile Monthly
Akouos Announces $7.5 Million Seed Round, Strategic License Agreement for Hearing Disorder Gene Therapy Platform | The Hearing Review
Lilly to acquire hearing loss startup Akouos for up to $618M - Boston Business Journal
Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
Akouos nabs meaty $105M raise, adds VC and biotech veterans to board | Fierce Biotech
S-1
Akouos Receives FDA Clearance of its IND Application for Gene Therapy Hearing Loss Treatment, AK-OTOF | Hearing Health & Technology Matters
Akouos Inc (@AkouosInc) / Twitter
Lilly snaps up hearing loss gene therapy player Akouos for $487M
Eli Lilly to buy gene therapy company Akouos for $487 million
Akouos Inc (@AkouosInc) / Twitter
About Us – Akouos
Eli Lilly to buy gene therapy company Akouos for $487 mln | Reuters
Akouos Announces Gene Therapy to Treat Genetic Hearing Loss | The Hearing Review
Lilly to Acquire Akouos | citybiz
Yuan Gao - Associate Director, Anatomy and Physiology - Akouos | LinkedIn
Akouos Inc. - MassBio
Lilly to acquires hearing loss company Akouos
Lilly's message is loud and clear: Akouos' AAV hearing loss therapy is worthwhile | BioWorld
Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF at ASGCT | Hearing Health & Technology Matters
Akouos stock soars 87% as Lilly nabs hearing loss gene therapy developer | Seeking Alpha
Akouos Eyes $100 Million IPO to Support Gene Therapy Programs for Hearing Loss | BioSpace
Akouos seeks a way to treat a gene-based hearing loss - STAT
Akouos Stock Soars as Eli Lilly Buys Genetic Therapies Company for $610 Million | Barron's
